Related Experiment Videos
Gynecomastia. A bothersome but readily treatable problem
1Division of General Internal Medicine, Stanford University School of Medicine, CA 94305-5320.
Postgraduate Medicine
|February 1, 1991
Summary
Gynecomastia, or male breast enlargement, is usually treatable. This case study shows tamoxifen citrate effectively treated gynecomastia caused by liver cirrhosis.
Area of Science:
- Endocrinology
- Hepatology
Background:
- Male breast enlargement (gynecomastia) can cause significant distress.
- Estrogenic excess is a common cause of gynecomastia.
Observation:
- A patient with gynecomastia secondary to liver cirrhosis was observed.
- The patient presented with symptoms of estrogenic imbalance.
Findings:
- The patient received a short course of tamoxifen citrate therapy.
- Prompt and positive response to tamoxifen citrate treatment was noted.
Implications:
- Tamoxifen citrate is a viable treatment option for gynecomastia in liver cirrhosis patients.
- Early intervention can alleviate psychological and physical distress associated with gynecomastia.